• Users Online: 266
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2021  |  Volume : 33  |  Issue : 1  |  Page : 29-32

Adaptive designs for clinical trials

Research Mentor, AMMA Healthcare Research Gurukul, Kochi, Kerala, India

Correspondence Address:
Dr. Praveen K Nirmalan
Research Mentor, AMMA Healthcare Research Gurukul, Kochi, Kerala
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/kjo.kjo_202_20

Rights and Permissions

The gold standard for interventional studies is the randomized controlled trial (RCT). The RCT follows a linear path with prespecified plans and a little option for flexibility within its implementation. The RCT is also resource and time-intensive and can be a limitation in epidemics or pandemics where more rapid responses can reduce adverse effects. Adaptive designs (ADs) allow for continuous evidence-based modifications to key elements of trial design even as data collection is going on. Reduced use of resources, reduced time to complete the trial, flexibility in the allocation of participants to study arms and improved likelihood for scientifically valid trial results are added advantages with AD. ADs can be applied from early-phase trials to confirmatory trials. In this paper, we introduce key aspects of AD that Ophthalmologists can apply to clinical trials in Ophthalmology. We briefly introduce the rationale for AD, commonly used terminology, and design elements.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded42    
    Comments [Add]    

Recommend this journal